Yahoo Finance26d
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
The combination of Illumina's Single Cell Prep, NovaSeq™ X Plus platform, 25B flow cell and DRAGEN™ analysis software creates a seamless end-to-end workflow enabling the high-throughput ...
Investing26d
Illumina and Broad Clinical Labs enhance single-cell research
Illumina's technology suite, including the NovaSeq™ X Plus platform, 25B flow cell, and DRAGEN™ analysis software, is designed to create an efficient end-to-end workflow for high-throughput ...
Investing26d
Illumina and Broad Clinical Labs enhance single-cell research
The integration of cutting-edge technologies is set to support the research community in undertaking billion-cell atlas studies, paving the way for new discoveries. Illumina's technology suite, ...
Pharmabiz23d
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
The combination of Illumina's Single Cell Prep, NovaSeq X Plus platform, 25B flow cell and DRAGEN analysis software creates a seamless end-to-end workflow enabling the high-throughput processing of ...
Yahoo Finance23d
ILMN Stock Might Rise From Collaboration With Broad Clinical Labs
Illumina, Inc. ILMN recently entered into a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects with cutting-edge tools and workflows. Together, the ...
TMCnet9d
Illumina addresses recent developments in China
"Our new fiscal 2025 guidance provides for limited further earnings contribution from China, and assumes a continuation of the macro trends we see today," said Ankur Dhingra, CFO of Illumina. "We will ...